Follow the Omega Healthcare Investors INC share price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, Omega Healthcare Investors INC has recorded 106 public disclosures. Market capitalisation: €15bn. The latest transaction was reported on 1 July 2026 (Attribution). Among the most active insiders: Ballew Neal. All data is free.
Analysts rate Omega Healthcare Investors INC Buy (bullish), based on 18 analysts. Average price target: US$50.67.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
25 of 106 declarations
Omega Healthcare Investors, Inc. (ticker: OHI) is a United States-listed healthcare real estate investment trust (REIT) traded on the NYSE. Headquartered in Hunt Valley, Maryland, the company has been investing in senior care since 1992 and has built a specialized platform focused on long-term healthcare real estate and related financing solutions. Its core portfolio is centered on skilled nursing facilities (SNFs) and assisted living facilities (ALFs), with additional exposure to other care assets, mortgages, loans to operators, and selected joint ventures. ([omegahealthcare.com](https://www.omegahealthcare.com/about-us?utm_source=openai)) Omega’s business model is that of a capital provider to the long-term care industry rather than a direct operator. The company acquires healthcare properties, structures long-term leases, provides secured and unsecured loans to operators or their principals, and has also begun using RIDEA structures for certain senior housing assets managed by third parties. This creates a differentiated profile within healthcare real estate: Omega monetizes the property and financing layer while leaving day-to-day clinical operations to third-party operators. ([sec.gov](https://www.sec.gov/Archives/edgar/data/888491/000088849126000008/ohi-20251231x10k.htm?utm_source=openai)) From a competitive standpoint, Omega occupies a niche position in a market supported by structural demand drivers such as population aging, rising need for post-acute and long-term care, and the specialized nature of healthcare real estate. Management describes the company as a preferred capital partner to third-party healthcare operators, reflecting its ability to provide flexible financing in a sector where access to capital is often critical. At the same time, the model carries meaningful operator risk, reimbursement risk, labor-cost pressure, and regulatory sensitivity, especially in the U.S. skilled nursing segment. ([omegahealthcare.com](https://www.omegahealthcare.com/about-us?utm_source=openai)) As of the end of 2025, Omega reported a portfolio of more than 1,000 healthcare facilities across 42 U.S. states, Washington, D.C., the United Kingdom, and Jersey, operated or managed by a broad base of third parties. The company also holds real estate loans and equity interests in entities that support the long-term care ecosystem. That geographic spread provides diversification, although the portfolio remains heavily concentrated in SNFs and ALFs, which continue to be the main drivers of the platform. ([sec.gov](https://www.sec.gov/Archives/edgar/data/888491/000088849126000008/ohi-20251231x10k.htm?utm_source=openai)) Recent developments have been constructive. In the first quarter of 2026, Omega announced a 9.9% equity investment in Saber Healthcare Holdings for $92.6 million. Throughout 2025, the company reported accretive capital deployment, portfolio activity, and upward revisions to adjusted FFO guidance, underscoring strong execution. For investors in France, Belgium, and Switzerland, OHI is best viewed as a NYSE-listed U.S. healthcare REIT with a yield-oriented profile and direct exposure to the long-term care real estate cycle. ([omegahealthcare.com](https://www.omegahealthcare.com/investors/news-events/press-releases/detail/343/omega-reports-first-quarter-2026-results-and-recent?utm_source=openai))